Sanofi agreed to buy Provention Bio Inc. in a $2.9 billion deal intended to bolster the French drugmaker's portfolio of diabetes medicines with a new therapy recently approved in the U.S.
Novo Nordisk said this week it will slash the list prices of several of its popular pre-filled insulin pens and vials by up to 75%, becoming the latest drugmaker to reduce the cost of the critical medicine for diabetes patients.
Despite being exposed to the tune of $8 to $10 million in the collapse of Silicon Valley Bank, Mark Cuban considers himself relatively lucky. Speaking on Twitter Spaces this weekend, Cuban laid bare what he believes the priorities should be for impacted parties: supporting startups to sign off their payroll and invoices to vendors, so their creditors in turn can continue to operate.
Zavzpret, a branded formulation of the generic drug zavegepant, is the "first and only" calcitonin gene-related peptide receptor antagonist nasal spray for treating migraines with or without an aura, or sensory disturbances such as flashes of light that can accompany a migraine.
Mexican pharmacies that cater to U.S. tourists are selling medications that appear safe but are frequently laced with deadly fentanyl and methamphetamine.